Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 173850-41-4 | MDL No. : | MFCD18830699 |
Formula : | C6H7NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JOWMDIFULFYASV-UHFFFAOYSA-N |
M.W : | 141.13 | Pubchem ID : | 10701915 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 32.59 |
TPSA : | 52.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.51 cm/s |
Log Po/w (iLOGP) : | 1.78 |
Log Po/w (XLOGP3) : | 0.92 |
Log Po/w (WLOGP) : | 0.85 |
Log Po/w (MLOGP) : | -0.02 |
Log Po/w (SILICOS-IT) : | 0.94 |
Consensus Log Po/w : | 0.9 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.47 |
Solubility : | 4.82 mg/ml ; 0.0342 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.6 |
Solubility : | 3.51 mg/ml ; 0.0248 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.69 |
Solubility : | 2.86 mg/ml ; 0.0203 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.21 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
59% | With silver tetrafluoroborate; phenol In tetrahydrofuran for 7 h; Reflux | General procedure: To a solution of alkynyl oxime ether 1 (0.15 mmol) in THF (5 mL) were added phenol (28 mg, 0.3 mmol) and AgBF4 (5.8 mg, 0.03 mmol), with a drying tube filled with silica gel at room temperature. After being stirred at reflux for 1-12 h (TLC monitoring), the reaction mixture was concentrated under reduced pressure. The residue was purified by preparative TLC (hexane/AcOEt=3-10:1) to afford isoxazole 3. The physical and spectroscopic data of 3a5 and 3j12h were in accord with those reported in the literature. |
[ 63366-79-0 ]
Ethyl 3-methylisoxazole-5-carboxylate
Similarity: 0.89
[ 1004-96-2 ]
Methyl 3-methylisoxazole-5-carboxylate
Similarity: 0.85
[ 105174-97-8 ]
Ethyl 3-bromoisoxazole-5-carboxylate
Similarity: 0.83
[ 13599-24-1 ]
Ethyl 3-phenylisoxazole-5-carboxylate
Similarity: 0.75
[ 51135-73-0 ]
Ethyl 5-methylisoxazole-4-carboxylate
Similarity: 0.73
[ 63366-79-0 ]
Ethyl 3-methylisoxazole-5-carboxylate
Similarity: 0.89
[ 105174-97-8 ]
Ethyl 3-bromoisoxazole-5-carboxylate
Similarity: 0.83
[ 261350-46-3 ]
4-Methylisoxazole-5-carboxylic acid
Similarity: 0.81
[ 13626-60-3 ]
3-Hydroxyisoxazole-5-carboxylic acid
Similarity: 0.80